PPT-Cancer Registration in the Era of Genomics: Integrating Germline and Somatic Genetic Data

Dr Fiona McRonald 11 th June 2019 NCRAS Public Health England National Disease Registration Service NDRS 2 NAACCRIACR Vancouver 2019 National Cancer Registration and Analysis Service NCRAS. in familial breast cancer . . can . lie deep in . family . tree. San Ming . Wang. University of Nebraska Medical Center. Genetically defined breast cancer. Sporadic . B. reast . C. ancer . caused by . in familial breast cancer . . can . lie deep in . family . tree. San Ming . Wang. University of Nebraska Medical Center. Genetically defined breast cancer. Sporadic . B. reast . C. ancer . caused by . Bioinformatics and Genomics. Applications:. Personalized cancer medicines. Disease determination . Pathway Analysis. Biomarker Discovery . An Interesting Point. “One . article estimated that the output from genomics may soon dwarf data heavyweights such as . NGS analysis. Ravi Madduri. madduri@anl.gov. Joint work with Paul . Davé. , Lukasz . Lacinski. , Alex Rodriguez, . Dinanath. . Sulakhe. , Ryan Chard and Ian Foster. Globus Genomics is developed, operated, and supported by researchers, developers, and . -Mutated Ovarian Cancer. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Ben Ho Park MD PhD. Johns Hopkins University. Financial Disclosures. I have financial relationships with commercial entities that are relevant to the content of this presentation.. Royalties from Horizon Discovery, LTD. February 6, 2013. Howard K. . Koh. , MD, MPH. Assistant Secretary for Health . U.S. Department of Health and Human Services . Progress Review Overview. Summarize the burden of Cancer in the U.S. and the role of Genomics . Dr Katie Snape. Joint Lead Consultant for Cancer Genetics,. South West Thames Regional Genetics Service. St George’s University Hospitals NHS Foundation Trust. Approval ID: GB-17285. Date of Preparation: June 2019. CancerGenetics@utsouthwestern.edu | 214 - 645 - 2563 Somatic and Germline Genetic Testing Somatic Testing Most cancer is the result of acquired, or somatic , mutations that occur in a cell. Cancers Views of genomics. [Solve challenges]. [Risks outweigh benefits]. Which of those applications of genomics do you approve of:. applications of genomics. % Approve/somewhat approve. Diagnose and plan treatments for cancer patients. Notes from meeting: February 21, 2023. GOALS. Improve collaboration and documentation towards assessment and recommendations related to genetic and genomic testing in young women with breast cancer. Offer recommendations to improve value and service for the ACBCYW . South West Genomic Laboratory Hub. 23. rd. February 2023. Haem germline findings. NGS testing for MPN. TATs. SNP arrays. WGS. 2. Haem Genomics update. A number of the genes included in haem NGS panels for their somatic actionability are also cancer susceptibility genes (CSGs) in the germline setting e.g. . Presented by: . Amit Levi. Class of 2022. Mentor:. Dr. . Xinbin. Chen. Department of Surgical & Radiological Sciences. P53 is a major tumor suppressor known as the “guardian of the genome”.. testing . pathways. Format. Round table discussion . 5 working groups . –. Breast, Colorectal, Ovarian, Other, TP53. Three documents on table. Individual variant testing scoring form (all to complete).